ATS seeks US trial for faster heart valve replacement technology
This article was originally published in Clinica
Executive Summary
ATS Medical has submitted to the FDA an investigational device exemption for permission to begin US clinical trials of a tissue valve product that it claims can be implanted more quickly and easily than current valve replacements.